Implementation of a Plan-Do-Study-Act framework to reduce unindicated surgical antimicrobial prophylaxis.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 11 09 2019
accepted: 29 09 2019
pubmed: 5 11 2019
medline: 5 9 2020
entrez: 5 11 2019
Statut: ppublish

Résumé

The goal of this study was to use a Plan-Do-Study-Act (PDSA) framework to reduce utilization of unindicated surgical antibiotic prophylaxis (SAP) for clean cases without foreign body implantation. This was a pre-post intervention study conducted at a single children's hospital comparing 6 months of retrospective preintervention data to 10 months of prospectively collected postintervention data. Interventions to reduce unindicated SAP included faculty meetings to review guidelines and establish consensus around inclusion criteria, publicizing guidelines with regular email reminders, and conducting ongoing compliance audits to root cause noncompliance. Early unanticipated noncompliant cases were associated with rotating trainees who prescribed SAP routinely without attending knowledge. A second PDSA cycle then included education-based emails targeting residents with mandatory feedback loop closure. Preintervention, 40.4% (107/265) of patients received unindicated SAP. Postintervention, the rate of unindicated SAP decreased to 15.4% (6/39) after the first month and 6.2% (20/323) after 10 months, reflecting an 85% reduction across periods (p < 0.01). There was no difference in the rate of surgical site infections between the pre and postintervention cohorts (0.36% vs. 0.67%, p = 1.00). Unindicated surgical antibiotic prophylaxis was significantly reduced by implementing a Plan-Do-Study-Act intervention targeting both faculty and trainees. Prospective comparative treatment study, level II.

Identifiants

pubmed: 31679771
pii: S0022-3468(19)30712-2
doi: 10.1016/j.jpedsurg.2019.09.059
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

86-89

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Mark Kashtan (M)

Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Michele Dawson (M)

Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Seema Anandalwar (S)

Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Jonathan Hills-Dunlap (J)

Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Dionne A Graham (DA)

Center for Applied Pediatric Quality Analytics, Boston Children's Hospital, Boston, MA.

Shawn Rangel (S)

Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA. Electronic address: shawn.rangel@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH